Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Super-Affinity Antibody

Human IgG4 (S228P) Isotype Control Antibody (13R4)

Catalog #:   FHK18120 Specific References (50) DATASHEET
Host species: Human
Isotype: IgG4, kappa
Applications: FCM, Isotype Control
Overview

Catalog No.

FHK18120

Host species

Human

Isotype

IgG4, kappa

Clonality

Monoclonal

Conjugation

Unconjugated

Concentration

3.8 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Applications

FCM, Isotype Control

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID

13R4

Data Image
  • SDS-PAGE
    SDS PAGE for Human IgG4 (S228P) Isotype Control Antibody (13R4)
References

Prevalence of dengue in febrile patients in Peru: A systematic review and meta-analysis., PMID:40526741

Negative associations of age and lifestyle factors with the antibody response to the COVID-19 vaccine BNT162b2 in health workers from Spain., PMID:40519918

Patrolling monocytes mediate virus neutralizing IgG effector functions: beyond neutralization capacity., PMID:40510351

Leveraging the Polymorphism of the Merozoite Surface Protein 2 (MSP2) to Engineer Molecular Tools for Predicting Malaria Episodes in a Community., PMID:40508084

Rapid detection of SARS-CoV-2 antigen based on IgG colloidal gold immunochromatographic strip., PMID:40506633

Detectable SARS-CoV-2 specific immune responses in recovered unvaccinated individuals 250 days post wild type infection., PMID:40498720

Seroprevalence of Toxoplasmosis and the Possible Role of C-Reactive Protein in the Pathogenesis of Myocardial Infarction in Patients from Iraq; A Case Control Study., PMID:40498362

Profiling of Anti-glycan IgA and IgG in Oral Fluid Using a Glycan Microarray., PMID:40498306

Efficacy of Subcutaneous Immunoglobulin in the Postoperative Management After Pediatric Living Donor Liver Transplantation., PMID:40495281

Evaluating the Effects of 60°C Heating for 90 Min on Bacterial Pathogen Viability and IgG Concentration in Bovine Colostrum., PMID:40493565

Kinetic of the Maternally-Derived Anti-Parvovirus IgG During the Neonatal Period: A Quantitative Assessment., PMID:40493541

Treatment Patterns and Disease Burden of Juvenile Myasthenia Gravis in the United States: A Cohort Study Using Health Care Claims Databases., PMID:40489715

Prevalence, knowledge, attitudes, and practices regarding Chagas disease in Guanare, Venezuela: a cross-sectional study., PMID:40484948

Serological analysis of gluten-related antibodies in idiopathic neuropathies and cerebellar ataxia., PMID:40481865

Immune age is correlated with decreased TCR clonal diversity and antibody response to SARS-CoV-2., PMID:40481111

Defining Aedes aegypti density thresholds for preventing human arboviral infections., PMID:40480602

Development of an oral gut-targeted rabies virus-like particles (RVLPs) vaccine with mucosal immune adjuvant LTB via delivering of localized-release microparticles., PMID:40476513

Avidity of pertussis toxin antibodies following vaccination with genetically versus chemically detoxified pertussis toxin-containing vaccines during pregnancy., PMID:40475765

Cumulative IgG reagent carryover detected in carryover evaluation of urinary total protein testing using AU5800 biochemistry analyzer., PMID:40469573

Seroepidemiological survey of the population 10 years after the implementation of the varicella vaccine 2-dose immunization strategy., PMID:40464766

Tracking the dynamics of antibody production against the SARS-CoV-2 virus after two doses of the mRNA vaccine BNT162b2., PMID:40461246

Decade-long protection of the mumps vaccine: Insights from a large-scale serological study., PMID:40460365

12-Month Outcomes of a Prospective Randomized Trial Investigating Effects of IVIG on Top of rATG Versus rATG Alone in Pre-Sensitized Kidney Transplant Recipients: The INHIBIT Study., PMID:40458542

Parameter-Optimized Fabrication of Submicron Nanoelectrospray Emitters for Enhanced Native Mass Spectrometry., PMID:40456619

Assessing COVID IGRA and IgG antibodies in healthcare workers post vaccination., PMID:40452527

Prevalence of epsilon toxin-producing Clostridium perfringens isolates among patients with multiple sclerosis and neuromyelitis optica spectrum disorder in Iran., PMID:40450217

Analysis of Increased False-Positive ELISA Results for HIV in the Blood of Donors Infected with SARS-CoV-2., PMID:40448880

Preparation of a Brucella multiepitope fusion protein based on bioinformatics and its application in serological diagnosis of human brucellosis., PMID:40447804

Detection of moderate to high antiphospholipid antibodies by chemiluminescence meets 2023 APS classification criteria., PMID:40447711

Immune persistence after 5 years of vaccination by Vi-DT vaccine among children below 2 years: Result from long-term observational study., PMID:40446606

Wb5, a novel biomarker for monitoring efficacy and success of mass drug administration programs for Wuchereria bancrofti elimination., PMID:40446061

The prevalence and associated risk factors of post-transplant Toxoplasma gondii infection among kidney transplant recipients and patients with uremia in Central-southern China., PMID:40446014

Comparative immune response of Typbar TCV® (typhoid conjugate vaccine) in extremes of age: An Indian experience., PMID:40445123

High-Efficient and Controllable Purification of Protein by Cyclic Injection in an Orthogonal Micro-Free-Flow Electrophoresis., PMID:40442025

Adults in Ghana generate higher and more durable neutralising antibody titres following primary course COVID-19 vaccination than matched UK adults: The HERITAGE Study., PMID:40437463

Systems serology-based comparison of humoral immune responses induced by liposome or aluminum hydroxide adjuvanted SARS-CoV-2 spike protein., PMID:40436929

Incidence of SARS-CoV-2 reinfection among blood donors from two Brazilian states in the post-vaccination period: a prospective cohort study., PMID:40435110

Chlamydia muridarum mutant CM-pGP3S as a novel attenuated live rectal vaccine protects against genital tract infection., PMID:40433661

Development of a Diagnostic Algorithm for Epstein-Barr Virus-Related Diseases: A Retrospective Observational Study., PMID:40432357

Long-Term Dynamics of SARS-CoV-2 Variant-Specific Neutralizing Antibodies Following mRNA Vaccination and Infection., PMID:40431687

Impact of Vaccine-Elicited Anti-Spike IgG4 Antibodies on Fc-Effector Functions Against SARS-CoV-2., PMID:40431678

Individuals Infected with SARS-CoV-2 Prior to COVID-19 Vaccination Maintain Vaccine-Induced RBD-Specific Antibody Levels and Viral Neutralization Activity for One Year., PMID:40431652

Evaluating SARS-CoV-2 T Cell Immunity in COVID-19-Naive Vaccinated Individuals with and Without Spike Protein IgG Antibodies., PMID:40430736

Serum Antibody Titres Against Porphyromonas gingivalis Fim A in Patients with Periodontitis with and Without Diabetes Mellitus Type 2., PMID:40429868

Integrated in-silico design and in vivo validation of multi-epitope vaccines for norovirus., PMID:40426240

Characterizing local antibody responses in the muscle of inclusion body myositis patients., PMID:40424896

PcrV in an intranasal adjuvanted tobacco mosaic virus conjugate vaccine mediates protection from Pseudomonas aeruginosa via an early Th1/Th17 skewed localized and systemic immune response., PMID:40424705

Effective cellular and neutralizing immunity against SARS-CoV-2 after mRNA booster vaccination is associated with pDC and B cell activation., PMID:40421016

Immunogenicity of COVID-19 Vaccination in Immunocompromised Patients (Auto-COVID-VACC): Protocol for Multicenter Prospective Noninterventional Study., PMID:40418566

Enteral immunization with live bacteria reprograms innate immune cells and protects neonatal foals from pneumonia., PMID:40415003

Datasheet
$ 160
Product specifications
50 μg 160 100 μg 260

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Human IgG4 (S228P) Isotype Control Antibody (13R4) [FHK18120]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only